Legal & General Group Plc - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 44 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2022$4,0000.0%1,6740.0%0.00%
Q1 2022$4,000
-60.0%
1,6740.0%0.00%
Q4 2021$10,000
-44.4%
1,6740.0%0.00%
Q3 2021$18,000
+200.0%
1,674
+182.3%
0.00%
Q2 2021$6,000
-40.0%
593
-17.3%
0.00%
Q1 2021$10,0007170.00%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Newtyn Management, LLC 1,540,920$2,311,3800.45%
Deuterium Capital Management, LLC 11,000$16,5000.03%
Duquesne Family Office 100,000$1500.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 112,900$169,3500.00%
LEO BROKERAGE, LLC 14,845$22,2680.00%
Ergoteles LLC 15,521$23,2820.00%
UBS Group AG 3,440$5,1600.00%
TWO SIGMA INVESTMENTS, LP 15,276$22,9140.00%
DIMENSIONAL FUND ADVISORS LP 11,570$17,3550.00%
BANK OF AMERICA CORP /DE/ 89,986$134,9790.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders